Pancreatic Cancer Action Network Adaptive Clinical Trial Adds New Investigational Treatment and Additional Sites - Pancreatic Cancer Action Network
Lilly-Incyte drug reduces eczema symptoms in treatment-resistant patients | S&P Global Market Intelligence
Anumana partners with Novartis to develop AI cardiovascular disease detection tools | MobiHealthNews
A middle-aged woman with nausea, weight loss, and orthostatic hypotension | Neurology
Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies - The Lancet
Eclipse and Mayo Clinic create Nucleus RadioPharma to better serve cancer patients - Mayo Clinic News Network
Q&A: Is it a migraine? Many don't realize what causes their suffering | The Seattle Times
New Novartis analyses for investigational inclisiran demonstrate consistently effective and sustained LDL-C reduction at month 17 regardless of age and gender
Amidst Novartis Takeover Rumors, The Medicines Company Announces Positive Cholesterol Data | BioSpace
B2 novartis | PDF
AI and 10 seconds of voice can screen for diabetes, new Mayo Clinic journal study reveals - PharmaLive
The Safety of a Plant-Based Nutraceutical for Behaviour in Cats and Dogs
Elevated lipoprotein(a) | Novartis
Novartis, Propeller Health co-package new asthma treatment | MobiHealthNews
Elsberg Syndrome Secondary to Cytomegalovirus Infection in an Immunocompetent Patient | Neurology Neuroimmunology & Neuroinflammation
Novartis taps growing Biofourmis for digital heart failure project | Fierce Biotech
Anumana and Novartis Collaborate To Deploy AI That Detects Heart Disease